Clinical outcomes following sirolimus-eluting stent implantation in patients with end-stage renal disease: Korean Multicenter Angioplasty Team (KOMATE) Registry

Korean Circulation Journal

Volumn 36, Issue 6, 2006, Pages 424-430

  Kim, Byoung Keuk ^a   Oh, Sungjin ^a   Jeon, Dong Woon ^a   Choi, Donghoon ^b   Jang, Yangsoo ^b   Kwon, Hyuck Moon ^c   Jung, Jae Hun ^d   Kwon, Kihwan ^e   Yang, Joo Young ^a  

^a National Health Insurance Corporation   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Hallym University College of Medicine   (South Korea)

^e Mokdong Hospital   (South Korea)

Author keywords

Coronary arterial disease; End stage renal disease; Stent

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 33746217506     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2006.36.6.424     Document Type: Article

References (23)

1. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
2. Huysmans K, Lins RL, Daelemans R, Zachee P, de Broe ME. Hypertension and accelerated atherosclerosis in end-stage renal disease. J Nephrol 1998;11:185-95.
3. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-69.
4. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Hartzler GO. Short-and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 1990;119:484-9.
5. Azar RR, Prpic R, Ho KK, et al. Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 2000;86:485-9.
6. Owen CH, Cummings RG, Sell TL, Schwab SJ, Jones RH, Glower DD. Coronary artery bypass grafting in patients with dialysis dependent renal failure. Ann Thorac Surg 1994;58:1729-33.
7. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
8. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23.
9. Tsagalou E, Chieffo A, Iakovou I, et al. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. J Am Coll Cardiol 2005;45:1570-3.
10. Ardissino D, Cavallini C, Bramucci E, et al. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA 2004;292:2727-34.
11. Kim W, Jeong MH, Cho JY, et al. The preventive effect on instent restenosis of overlapped drug-eluting stents for treating diffuse coronary artery disease. Korean Circ J 2006;36:17-23.
12. American College of Cardiology and American Heart Association Task Force. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment Diagnostic and Therapeutic Cardiovascular Procesure (Committee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 1993;22:2033-54.
13. le Feuvre C, Dambrin G, Helft G, et al. Clinical outcome following coronary angioplasty in dialysis patients: a case-control study in the era of coronary stenting. Heart 2001;85:556-60.
14. Tadros GM, Herzog CA. Percutaneous coronary intervention in chronic kidney disease patients. J Nephrol 2004;17:364-8.
15. Amann K, Ritz E. Cardiac disease in chronic uremia: pathophysiology. Adv Ren Replace Ther 1997;4:212-24.
16. Cheon IS, Choi JH, Kim KL, et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Korean Circ J 2004;34:1033-42.
17. Serruys PW, van Hout B, Bonnier H, et al. Randomized comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998;352:673-81.
18. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999;99:2434-9.
19. Lee YS, Kim KS, Hyun DW, et al. The change of arterial stiffness according to dialysis in patients with end-stage renal disease. Korean Circ J 2004;34:865-73.
20. Hoffmann R, Mintz GS, Mehran R, et al. Tissue proliferation within and surrounding Palmaz-Schatz stents is dependent on the aggressiveness of stent implantation technique. Am J Cardiol 1999;83:1170-4.
21. Viener A, Aviram M, Better OS, Brook JG. Enhanced in vitro platelet aggregation in hemodialysis patients. Nephron 1986;43: 139-43.
22. Lemos PA, Arampatzis CA, Hoye A, et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 2005;95:167-72.
23. Halkin A, Mehran R, Casey CW, et al. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial. Am Heart J 2005;150:1163-70.